Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 12, 2026
Why Is WeRide Inc. (WRD) Stock Down -9.32% Today?

Why Is WeRide Inc. (WRD) Stock Down -9.32% Today?

Key Takeaways

  • WRD shares fell 9.32% to $5.74 as of 3:29 p.m. ET Wednesday, down from a prior close of $6.33.
  • The move followed second-quarter results that delivered stronger-than-expected revenue but a wider-than-expected net loss.
  • Record gross margin, accelerating overseas robotaxi growth, and rising ADAS volumes were overshadowed by profitability concerns and a sell-the-news reaction.
  • The decline was company-specific, with WRD sharply underperforming a modestly higher broader market.
  • Traders are now watching the $5.70 support area and management's path toward cash-flow breakeven.

Opening Summary

WeRide Inc. (WRD) is a global autonomous-driving technology company and the first publicly traded robotaxi operator, with products spanning Robotaxi, Robobus, Robovan, Robosweeper, and advanced driver-assistance systems from L2 to L4. In afternoon trading Wednesday, shares of WRD were down 9.32% at $5.74, compared with the previous session's close of $6.33. The immediate catalyst was the company's second-quarter earnings report, which showed rapid revenue growth but a loss that came in above analyst expectations.

Earnings Results: Strong Growth, Wider-Than-Expected Loss

The earnings-driven move lower came despite an upbeat top-line story. Revenue rose 82% year over year in local-currency terms to RMB231.7 million, or about $34.15 million in U.S. dollar terms, as growth accelerated across L4 autonomous driving, L2/L3 ADAS, and international operations. Overseas revenue surged 164% and accounted for nearly 40% of total revenue, helped by robotaxi deployments and expansion in the Middle East, Europe, and Southeast Asia.

Gross profit climbed 143% to RMB87 million, and gross margin reached a record 37.5%, up from 28.1% a year earlier. Management attributed the improvement to higher-margin, asset-light L4 services and a stronger mix of AI-service revenue.

However, the bottom line underwhelmed. The company posted a second-quarter net loss of roughly RMB401 million, wider than the market's expectation for a loss closer to RMB301 million. On a per-share basis, the diluted loss of RMB1.23 compared with a consensus forecast of about RMB0.89. That gap, rather than the revenue beat, dominated the market reaction.

Profitability Concerns Overshadow Operating Momentum

Investors also weighed continued heavy spending against an elevated valuation. Research and development expense rose 36% as WeRide invested in AI infrastructure and foundation models. While the company held about RMB5.4 billion in cash and other liquid financial resources at the end of June, profitability remains years away by management's own framework: the company is targeting positive cash flow in a single quarter by 2028 and full-year breakeven in 2029.

With the stock carrying a price-to-sales multiple around 20 despite negative earnings, the results left little room for a bottom-line miss. The pullback also reflected a sell-the-news dynamic after WRD had climbed from the high $5.80s in early August to above $6.30 heading into the report.

Market Context and Trading Activity

The decline looked stock-specific rather than macro-driven. Major U.S. indexes held modest gains Wednesday following an in-line July inflation reading, with the S&P 500 up about 0.2% and the Nasdaq Composite up roughly 0.4% at midday. WRD moved sharply against that backdrop.

Trading activity was heavy. More than 7 million shares had changed hands by mid-afternoon, compared with a 10-day average near 1.8 million shares, indicating conviction behind the selloff. The stock opened around $6.27, below the prior close, and slid to an intraday low near $5.69, testing the lower end of its recent trading range and turning the $6.00 level back into resistance.

What Comes Next for WRD

Attention now shifts to whether WeRide can convert its revenue momentum into narrower losses. Key milestones include scaling L2-equipped vehicle deliveries beyond 100,000 by year-end, expanding robotaxi operations in new international markets, and protecting gross margin as the fleet grows. Regulatory developments across China, the Middle East, and Europe, along with competition in autonomous driving, remain important swing factors. Risks include ongoing cash burn, execution challenges in new cities, and the possibility that autonomous-driving sentiment stays volatile after the post-earnings reset.

Trending AI Robots

Traders looking for a systematic way to monitor opportunities in stocks such as WRD can visit Tickeron's Trending AI Robots page. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols. Explore the page to see which AI-driven strategies are currently gaining traction.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WRD

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


WRD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for WRD turned positive on July 09, 2026. Looking at past instances where WRD's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on WRD as a result. In of 30 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

WRD moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WRD advanced for three days, in of 78 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 47 cases where WRD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WRD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WRD broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.962) is normal, around the industry mean (28.479). P/E Ratio (0.000) is within average values for comparable stocks, (81.364). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.725). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (19.685) is also within normal values, averaging (69.517).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WRD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WRD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.31B. The market cap for tickers in the group ranges from 291 to 239.15B. SAP holds the highest valuation in this group at 239.15B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 8%. YXT experienced the highest price growth at 62%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 4% and the average quarterly volume growth was -61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
WRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Details
Industry
Oil And Gas Production
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Why Is WeRide Inc. (WRD) Stock Down -9.32% Today?